Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1987Obstetric Anesthesia Digest

Risks of Anticoagulant Therapy in Pregnant Women with Artificial Heart Valves

View Full Paper
Ask AI
Bookmark
Share

Key result

Anticoagulation poses distinct maternal and fetal risks in pregnant women with prosthetic heart valves.

Authors

IIIgnacio Iturbe-AlessioInstituto Nacional de CardiologíaMFMaría del Carmen FonsecaInstituto Nacional de CardiologíaOMOsvaldo MutchinikInstituto Nacional de Cardiología

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Iturbe-Alessio et al. (1987) studied this question. Anticoagulant therapy presents specific risks for pregnant women with artificial heart valves.

synapsesocial.com/papers/6ab471a57f5fa3cef2c0861bhttps://doi.org/10.1097/00132582-198707000-00006
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Anticoagulation in Pregnant Women with Mechanical Heart Valve Prostheses2021 · 2 citations
  2. 2Anticoagulant therapy in pregnant women with mechanical and bioprosthetic heart valves2024 · 2 citations
  3. 3Anticoagulant therapy in pregnancy1996 · 35 citations
  4. 4Anticoagulation in Pregnant Women With Prosthetic Heart Valves2004 · 85 citations
  5. 5Anticoagulant Therapy in Pregnant Women with Mechanical Heart Valves: Italian Federation of Centers for Diagnosis and Surveillance of the Antithrombotic Therapies (FCSA) Position Paper2024 · 11 citations